| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 602,182 | 749,553 | 922,401 | | Cost of Revenue | 526,604 | 599,321 | 625,105 | | | Gross Profit | 75,578 | 150,232 | 297,296 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 16,901 | 18,756 | 20,344 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 58,677 | 131,476 | 276,952 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (49) | 615 | 1,851 | | Earnings Before Interest And Taxes | 91,054 | 166,073 | 311,568 | | Interest Expense | 28,871 | 21,689 | 7,280 | | Income Before Tax | 62,183 | 144,384 | 304,288 | | Income Tax Expense | 20,419 | 46,616 | 101,624 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 41,764 | 97,768 | 202,664 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 41,764 | 97,768 | 202,664 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $41,764 | $97,768 | $202,664 |
|
1.48% Nasdaq 
Income Statement
